Polymedco Announces: New Published Research Supports Fecal Immunochemical Testing (FIT) as the Most Clinically and Cost Effective Noninvasive Colorectal Cancer Screening (CRC) method
Polymedco announces US FDA clearance of the PATHFAST high-sensitivity cardiac troponin I (hs-cTnI-II) test as an aid in the diagnosis of myocardial infarction